Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 460

1.
2.

[Pregnancy, contraception and HRT and venous thromboembolism].

Conard J, Gompel A.

Rev Prat. 2007 Apr 15;57(7):759-66. French.

PMID:
17626321
3.

Hormone therapy and thromboembolic disease.

Battaglioli T, Martinelli I.

Curr Opin Hematol. 2007 Sep;14(5):488-93. Review.

PMID:
17934355
4.

Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.

Waselenko JK, Nace MC, Alving B.

Semin Thromb Hemost. 1998;24 Suppl 1:33-9. Review.

PMID:
9840690
5.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

Health Technol Assess. 2006 Apr;10(11):1-110. Review.

6.

Hormones and pregnancy: thromboembolic risks for women.

Kujovich JL.

Br J Haematol. 2004 Aug;126(4):443-54. Review.

PMID:
15287937
7.

A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.

Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF.

Arch Intern Med. 1997 Jul 28;157(14):1522-30. Review.

PMID:
9236553
8.

Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.

Herrington DM, Vittinghoff E, Howard TD, Major DA, Owen J, Reboussin DM, Bowden D, Bittner V, Simon JA, Grady D, Hulley SB.

Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):1012-7.

9.

Risk of venous thromboembolism with third-generation oral contraceptives: A review.

Weiss G.

Am J Obstet Gynecol. 1999 Feb;180(2 Pt 2):295-301.

PMID:
9988833
10.
11.

Low fibrinogen level: A predisposing factor for venous thromboembolic events with hormone replacement therapy.

Whiteman MK, Cui Y, Flaws JA, Espeland M, Bush TL.

Am J Hematol. 1999 Aug;61(4):271-3.

12.

Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease.

Mammen EF.

Hematol Oncol Clin North Am. 2000 Oct;14(5):1045-59, vii-viii. Review.

PMID:
11005033
13.

Venous thromboembolism in women: a specific reproductive health risk.

ESHRE Capri Workshop Group.

Hum Reprod Update. 2013 Sep-Oct;19(5):471-82. doi: 10.1093/humupd/dmt028. Epub 2013 Jul 3. Review.

14.

[Contraceptive agents and risk of thrombosis].

Maurer-Major E, Keller PJ.

Praxis (Bern 1994). 1997 Oct 1;86(40):1543-8. Review. German.

PMID:
9417570
15.

[Effect of hormonal changes in women on hemostasis].

Malý J, Dulícek P.

Vnitr Lek. 2002 Dec;48(12):1169-73. Czech.

PMID:
12642936
17.

Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.

Lowe G, Woodward M, Vessey M, Rumley A, Gough P, Daly E.

Thromb Haemost. 2000 Apr;83(4):530-5.

PMID:
10780311
18.

Combined hormonal contraception and venous thromboembolism.

Martínez F, Avecilla A.

Eur J Contracept Reprod Health Care. 2007 Jun;12(2):97-106. Review.

PMID:
17559006
19.

Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?

Odlind V, Milsom I, Persson I, Victor A.

Acta Obstet Gynecol Scand. 2002 Jun;81(6):482-90.

PMID:
12047300
20.

Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.

DeSancho MT, Dorff T, Rand JH.

Blood Coagul Fibrinolysis. 2010 Sep;21(6):534-8. doi: 10.1097/MBC.0b013e32833b2b84.

PMID:
20581664
Items per page

Supplemental Content

Write to the Help Desk